Walled Lake Planning & Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Walled Lake Planning & Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-128	Closed	-$21K	–	195
2021 Q3	$21K	Buy	128 +1	+0.8%	+$168	0.01%	216
2021 Q2	$21K	Hold	127	–	–	0.01%	201
2021 Q1	$19K	Buy	127 +42	+49%	+$6.67K	0.01%	198
2020 Q4	$13K	Hold	85	–	–	0.01%	204
2020 Q3	$12K	Buy	85 +4	+5%	+$543	0.01%	206
2020 Q2	$11K	Hold	81	–	–	0.01%	192
2020 Q1	$9K	Hold	81	–	–	0.01%	194
2019 Q4	$10K	Buy	+81	New	+$9.04K	0.01%	202

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Walled Lake Planning & Wealth Management's IBB Position: Q4 2021 in Review

Walled Lake Planning & Wealth Management sold out of iShares Biotechnology ETF (IBB) in Q4 2021, closing a stake of 128 shares — an estimated $21K sold.

Walled Lake Planning & Wealth Management first reported a position in IBB in Q4 2019 and held it in 8 quarters. The position peaked at $21K in Q3 2021. 962 funds tracked by Wall St. Rank hold IBB as of Q4 2021.

Walled Lake Planning & Wealth Management reported no remaining iShares Biotechnology ETF position as of Q4 2021 after selling out during the quarter.
Walled Lake Planning & Wealth Management sold 128 iShares Biotechnology ETF shares in Q4 2021, an estimated $21K.
Walled Lake Planning & Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 8 quarters.
Walled Lake Planning & Wealth Management's iShares Biotechnology ETF position peaked at $21K in Q3 2021.
962 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2021.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q4 2021, filed 10 Feb 2022.